SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060482
Filing Date
2024-05-15
Accepted
2024-05-15 16:15:47
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atha-20240331.htm   iXBRL 10-Q 1919961
2 EX-31.1 atha-ex31_1.htm EX-31.1 14997
3 EX-31.2 atha-ex31_2.htm EX-31.2 14902
4 EX-32.1 atha-ex32_1.htm EX-32.1 8638
5 EX-32.2 atha-ex32_2.htm EX-32.2 7745
6 GRAPHIC img106164450_0.jpg GRAPHIC 87864
  Complete submission text file 0000950170-24-060482.txt   7191641

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20240331.xsd EX-101.SCH 972540
70 EXTRACTED XBRL INSTANCE DOCUMENT atha-20240331_htm.xml XML 1029100
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 24950967
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)